海角乱伦社区

Skip to main content
Union University

Scholarship Project

Jennifer S. Byrd

Associate Professor of Pharmacy Practice

Visit University Profile

22 Results

Book(s), Monograph(s) or Book Chapter(s)

See Book Project Profile

Peer-Reviewed Journal Article(s)

  • "," Innov Pharm, 12(1). (March 2021) (with Peters, MJ)
  • "Pharmacologic therapy for non-alcoholic fatty liver disease in adults," Pharmacotherapy. (January 2012) (with Scott Malinowski, Pharm.D.; Allison Bell, Pharm.D.; Marion R. Wofford, M.D., MPH; Daniel M. Riche, Pharm.D., BCPS, CDE)
  • "DPP-4 inhibitors and angioedema: a cause for concern?," Annals of Allergy Asthma and Immunology, Issue 106 Vol 5, 436-438. (January 2011) (with Deborah Minor, Pharm.D.)
  • "Angioedema: presentation and treatment," Mississippi Pharmacist, Spring Issue. (January 2011) (with Deborah Minor, Pharm.D.)
  • "Feasibility of contracting for medication therapy management services in a physician鈥檚 office," American Journal of Health System Pharmacy, Issue 66, 1390-1393. (January 2009) (with Jeremy Thomas, Pharm.D., Michelle Zingone, Pharm.D., Christa George, Pharm.D.)

Presentation(s)

  • "Cardiology overview" TPA Clinical Pharmacy Pathway Certificate Training Program, Nashville, TN. (April 2020)
  • "Clinical pearls in heart failure" West Tennessee Pharmacists Association, Jackson, TN. (April 2020)
  • "Impact of a collaborative, outpatient chronic heart failure clinic managed by pharmacists and nurse practitioners on heart failure outcomes" (with Wilson, DH, Patterson, A, Murphy, BL, Etghayi, K)
    Mid-year Clinical Meeting of the American Society of Health-Systems Pharmacists, Las Vegas, NV. (December 2019)
  • "Use of natural products: clinical case studies" Tennessee Pharmacists Association Summer Meeting, Murfreesboro, TN. (July 2019)
  • "Validation evidence for PharmD student case presentations: a pilot study" (with Peeters, MJ)
    American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL. (July 2019)
  • "Evaluating the timing of antihypertensive administration among patients" (with Parrish, JB)
    Tennessee Society of Health Systems Pharmacists Winter Meeting, Nashville, TN. (February 2019)
  • "Evaluating hospitalizations for adverse drug reactions in local clinic patients" (with Rice, T)
    Tennessee Society of Health Systems Pharmacists Winter Meeting, Nashville, TN. (February 2019)
  • "Evaluating the presence of comorbid conditions and characterizing the risk factors included in the amputation risk boxed warning of canagliflozin compared with other SGLT-2 inhibitors" (with Horn, B, Michael, M, Kuhl, D)
    American Pharmacist Association Annual Meeting, Nashville, TN. (March 2018)
  • "Fostering self-awareness through a focus on innovation, leadership, and professionalism" (with Jones, KM)
    American Association of Colleges of Pharmacy Annual Meeting, Nashville, TN. (July 2017)
  • "Marketing clinical pharmacy services" (with Nelson, B, Simpson, C)
    Tennessee Pharmacists Association Summer Meeting, Kingsport, TN. (July 2017)
  • "Cardiovascular disease risk with hypoglycemic agents" Tennessee Society of Health Systems Pharmacists Summer Meeting, Kingsport, TN. (July 2017)
  • "Updates and pearls of type 2 diabetes management" West Tennessee Pharmacists Association, Jackson, TN. (January 2017)
  • "Pharmacists as providers: billing, quality, and outcomes" (with Cross LB)
    2016 Tennessee Pharmacists Association Summer Meeting Continuing Education Session, Point Clear, AL. (January 2016)
  • "Assessing the impact of pharmacist interventions versus standard care in the outpatient management of chronic obstructive pulmonary disease" (with Folz HN, Murphy BL, Day MG)
    2015 American Pharmacists Association Annual Meeting Resident Poster Session, San Diego, CA. (January 2015)
  • "Implementation of ambulatory care pharmacy services in a private physicians office and its impact on patients with diabetes" (with Murphy BL, Kuhl DA, and Midha S)
    2014 APhA Annual Meeting Professional Poster Session, Orlando, FL. (January 2014)
  • "A retrospective analysis of angioedema associated with dipeptidyl peptidase IV inhibitors" (with Deborah Minor, Pharm.D., Sharon Dickey, Pharm.D., Gailen Marshall, M.D., Richard deShazo, M.D.)
    Mid-South Pharmacy Residents Conference, Memphis, TN. (May 2011)
  • "Monitoring anti-Xa levels in obese patients receiving therapeutic dose of enoxaparin" (with Marilyn Lee, Pharm.D. and David Kuhl, Pharm.D.)
    43rd Mid-Year Clinical Meeting of the American Society of Health-Systems Pharmacists, Orlando, FL. (December 2008)